ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE

[1]  M. Lepow,et al.  Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age. , 1985, The Journal of pediatrics.

[2]  P. Mäkelä,et al.  Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. , 1984, Pediatrics.

[3]  M. Lepow,et al.  Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults. , 1984, The Journal of infectious diseases.

[4]  R. Munson,et al.  Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults. , 1984, The Journal of pediatrics.

[5]  P. Kowey,et al.  Sustained arrhythmias in hypertrophic obstructive cardiomyopathy. , 1984, The New England journal of medicine.

[6]  P. Mäkelä,et al.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. , 1984, The New England journal of medicine.

[7]  H. Peltola,et al.  Systemic Haemophilus influenzae Infection in Finland , 1984, Clinical pediatrics.

[8]  C. Berkowitz,et al.  ENHANCED IMMUNOGENICITY IN YOUNG INFANTS OF A NEW HAEMOPHILUS INFLUENZAE TYPE B(HIB) CAPSULAR POLYSACCHARIDE(PRP)-DIPHTHERIA TOXOID(D) CONJUGATE VACCINE , 1984, Pediatric Research.

[9]  J. Zahradnik,et al.  AUGMENTED ANTIBODY (Ab) RESPONSES IN INFANTS ADMINISTERED A NEW HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) DIPHTHERIA TOXOID CONJUGATE VACCINE (PRP-D) , 1984, Pediatric Research.

[10]  U. Rosenhall,et al.  Incidence and prognosis of Haemophilus influenzae meningitis in children in a Swedish region , 1984, Pediatric infectious disease.

[11]  P. Mäkelä,et al.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. , 1983, The Journal of infectious diseases.

[12]  R. Schneerson,et al.  Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates , 1983, Infection and immunity.

[13]  P. Anderson.  Antibody Responses to Haemophilus influenzae Type b and Diphtheria Toxin Induced by Conjugates of Oligosaccharides of the Type b Capsule with the Nontoxic Protein CRM197 , 1983, Infection and immunity.

[14]  H. Margolis,et al.  HAEMOPHILUS INFLUENZAE DISEASE IN ALASKAN ESKIMOS: CHARACTERISTICS OF A POPULATION WITH AN UNUSUAL INCIDENCE OF INVASIVE DISEASE , 1981, The Lancet.

[15]  F. Denis,et al.  [An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970-1979]. , 1981, Bulletin of the World Health Organization.

[16]  L. Thrupp,et al.  Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. , 1980, The Journal of pediatrics.

[17]  B. Plikaytis,et al.  Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. , 1979, The New England journal of medicine.

[18]  U. Alon,et al.  Neurological sequelae of septic meningitis. A follow-up study of 65 children. , 1979, Israel journal of medical sciences.

[19]  M. Pichichero,et al.  350 DIPHTHERIA-PERTUSSIS-TETANUS VACCINE: REACTOGENICITY OF COMMERCIAL PRODUCTS , 1978, Pediatric Research.

[20]  P. Anderson.  Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B. , 1978, Journal of immunology.

[21]  P. Mäkelä,et al.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. , 1977, Pediatrics.

[22]  E. Ruoslahti,et al.  Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. , 1977, The Journal of infectious diseases.

[23]  S. Stewart.  AMPICILLIN-RESISTANT HÆMOPHILUS INFLUENZÆ , 1974 .

[24]  S. Sell,et al.  Long-term sequelae of Hemophilus influenzae meningitis. , 1972, Pediatrics.

[25]  P. Anderson,et al.  Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. , 1972, The Journal of clinical investigation.

[26]  J. C. Parke,et al.  Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b. , 1971, Journal of immunology.

[27]  R. Michaels.  Increase in influenzal meningitis. , 1971, The New England journal of medicine.